Omriclo Launch: Celltrion Expands in Europe – Smart Today

by Archynetys World Desk

Smart Today = Reporter Kim Se-hyung | Celltrion’s chronic idiopathic urticaria treatment ‘Omriclo‘ (ingredient name: omalizumab, 75mg/150mg), which was launched in Europe last September, is being sold in Germany and Korea.spain∙ …

Related Posts

Leave a Comment